Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Kane

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|January 1, 1996
Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIIIT L Ortel, K D Moore, M Ezban, et al.
Biochemistry|October 6, 1987
Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeatsW H Kane, A Ichinose, F S Hagen, et al.
The Journal of Biological Chemistry|February 25, 1992
Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domainT L Ortel, D Devore-Carter, M Quinn-Allen, et al.
Biochimica Et Biophysica Acta|July 29, 1987
Activation of coagulation factor V by calcium-dependent proteinaseG M Rodgers, J Y Cong, D E Goll, et al.
Biochemistry|March 28, 1995
Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.
Blood|November 1, 1979
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorderJ P Miletich, W H Kane, S L Hofmann, et al.
Biochemistry|July 11, 2001
Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor VaA Srivastava, M A Quinn-Allen, S W Kim, et al.
The Journal of Clinical Investigation|December 1, 1992
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.
Blood|August 15, 1993
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuriaT Wiedmer, S E Hall, T L Ortel, et al.
Clinical Chemistry|October 1, 1994
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|January 1, 1996
Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIIIT L Ortel, K D Moore, M Ezban, et al.
Biochemistry|October 6, 1987
Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeatsW H Kane, A Ichinose, F S Hagen, et al.
The Journal of Biological Chemistry|February 25, 1992
Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domainT L Ortel, D Devore-Carter, M Quinn-Allen, et al.
Biochimica Et Biophysica Acta|July 29, 1987
Activation of coagulation factor V by calcium-dependent proteinaseG M Rodgers, J Y Cong, D E Goll, et al.
Biochemistry|March 28, 1995
Thrombin-catalyzed activation of recombinant human factor VF G Keller, T L Ortel, M A Quinn-Allen, et al.
Blood|November 1, 1979
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorderJ P Miletich, W H Kane, S L Hofmann, et al.
Biochemistry|July 11, 2001
Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor VaA Srivastava, M A Quinn-Allen, S W Kim, et al.
The Journal of Clinical Investigation|December 1, 1992
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activityT L Ortel, M A Quinn-Allen, L A Charles, et al.
Blood|August 15, 1993
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuriaT Wiedmer, S E Hall, T L Ortel, et al.
Clinical Chemistry|October 1, 1994
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.
Pageof 3